Gene Editing and X-Vivo - What's Next?

I was actually stunned by what Seattle Children's had been able to do. And so the data was very compelling in terms of what they'd worked out. Atlas and RA Capital had led the series A. Did I say series B? They'd raise the A. So it was Atlas and RA led A and then Ulta was also a participant.